ArticleFrontiers in immunology2024

IL6 receptor inhibitors: exploring the therapeutic potential across multiple diseases through drug target Mendelian randomization.

Chong Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.